Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
JACKSONVILLE, Fla., March 10, 2017 -- ParkerVision, Inc. (Nasdaq:PRKR), a developer and marketer of semiconductor technology solutions for wireless applications, today announced that it has completed the sale of approximately 4.1 million shares of its common stock at an average price of $2.46 per share, for aggregate gross proceeds of $10 million, pursuant to an At Market Issuance Sales Agreement (“ATM Agreement”). The ATM Agreement, which the Company entered into with FBR Capital Markets in December 2016, has now concluded. In addition to the ATM Agreement proceeds, one of the Company’s newly appointed directors, Mr. Paul Rosenbaum, purchased approximately $170,000 of the Company’s unregistered common stock at market in February.
ParkerVision CEO, Jeffrey Parker commented, “The funds raised from the ATM Agreement provide us with the flexibility and financial pathway to achieve our strategic objectives. We are well-positioned to successfully launch our new Wi-Fi product line that we believe will have broad appeal to a significant consumer market. Our patented RF energy sampling down conversion technology, which has been broadly deployed in other wireless devices, enables us to offer very competitive products in the residential Wi-Fi market.”
Regarding the Company’s upcoming hearing at the International Trade Commission, Mr. Parker commented, “We look forward to presenting the merits of our infringement case to the ITC next week as we strive to halt the unauthorized use of our patented technologies. While the market has benefited from the adoption of our technology, we continue to seek efficient ways to be fairly compensated for the investments ParkerVision has made and continues to make.”
About ParkerVision
ParkerVision, Inc. designs, develops and markets its proprietary radio-frequency (RF) technologies that enable advanced wireless solutions for current and next generation communications networks. Protected by a highly-regarded, worldwide patent portfolio, the Company’s solutions for wireless transfer of RF waveforms address the needs of a broad range of wirelessly connected devices for high levels of RF performance coupled with best-in-class power consumption. For more information please visit www.parkervision.com. (PRKR-G).
Safe Harbor Statement
This press release contains forward-looking information. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties which are disclosed in the Company's SEC reports, including the Form 10-K for the year ended December 31, 2015 and the Forms 10-Q for the quarters ended March 31, June 30, and September 30, 2016. These risks and uncertainties could cause actual results to differ materially from those currently anticipated or projected.
CONTACT: Cindy Poehlman Chief Financial Officer ParkerVision, Inc. 904-732-6100 [email protected] or Matt Steinburg The Piacente Group 212-481-2050 [email protected]
